Online Matchmaking: EP PerMed Twinning Call 2026

25 Sept 2025 – 26 Feb 2026

Register
Register
Register

ExpertiseUpdated on 23 October 2025

Machine Learning

Computer Engineer at Kedi Mobile Applications

Muğla, Türkiye

About

Seeking a Twinning partnership under the EP PerMed Twinning Call 2026 to advance AI-driven, bioinformatics-based solutions for personalised medicine. The initiative focuses on transferring expertise in multi-omics integration, predictive modelling, and data-driven decision support, accelerating the cross-border implementation of innovative precision-health technologies.

Field

  • Screening & early detection programs (risk stratification, predictive tools)
  • Personalised treatment pathways (tailored therapies, precision dosing)
  • Patient management systems (decision-support tools, clinical workflows)
  • Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
  • Clinical decision support systems for personalised medicine
  • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)

Organisation

Kedi Mobile Applications

Company/SME

Mugla, Türkiye

Similar opportunities

  • Expertise

    Offering Expertise of the group of Prof. Markus Scholz

    • Clinical decision support systems for personalised medicine
    • Theranostics (combined diagnostic + therapeutic approaches)
    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Screening & early detection programs (risk stratification, predictive tools)

    Peter Ahnert

    Senior Scientist at Leipzig University - Medical Faculty - IMISE

    Leipzig, Germany

  • Expertise

    Offering expertise of the group of Prof. Markus Scholz

    • Clinical decision support systems for personalised medicine
    • Theranostics (combined diagnostic + therapeutic approaches)
    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Screening & early detection programs (risk stratification, predictive tools)

    Peter Ahnert

    Senior Scientist at Leipzig University - Medical Faculty - IMISE

    Leipzig, Germany

  • Expertise

    Offering expertise of the group of Prof. Markus Scholz

    • Clinical decision support systems for personalised medicine
    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Partial adoption of a PM solution (testing selected modules/components)
    • Screening & early detection programs (risk stratification, predictive tools)

    Peter Ahnert

    Senior Scientist at Leipzig University - Medical Faculty - IMISE

    Leipzig, Germany